113 related articles for article (PubMed ID: 3946388)
41. [Seroepidemiology of cholera in Mexico].
González-Bonilla C; Valle-Valdez JG; Núñez-León A; Moguel-Pech L; Villanueva-Zamudio A
Rev Latinoam Microbiol; 1994; 36(4):253-6. PubMed ID: 7701134
[TBL] [Abstract][Full Text] [Related]
42. [Method of preparation of erythrocytic diagnostic agents for detection of antitoxic and antibacterial antibodies in El Tor cholera].
Tsybin BP; Taran IF
Lab Delo; 1975; (3):170-2. PubMed ID: 48596
[No Abstract] [Full Text] [Related]
43. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.
Hochstein HD; Feeley JC; DeWitt WE
Appl Microbiol; 1970 May; 19(5):742-5. PubMed ID: 5463574
[TBL] [Abstract][Full Text] [Related]
44. Cholera toxoid boosts serum Escherichia coli antitoxin in humans.
Nalin DR; al-Mahmud A; Curlin G; Ahmed A; Peterson J
Infect Immun; 1974 Oct; 10(4):747-9. PubMed ID: 4609909
[TBL] [Abstract][Full Text] [Related]
45. Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin.
Sack DA; Huda S; Neogi PK; Daniel RR; Spira WM
J Clin Microbiol; 1980 Jan; 11(1):35-40. PubMed ID: 6986402
[TBL] [Abstract][Full Text] [Related]
46. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
Kay RA; Ferguson A
Immunology; 1989 Mar; 66(3):410-5. PubMed ID: 2703255
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of the ELISA method for cholera toxin determination in Vibrio cholerae cultures].
González-Bonilla C; Gutiérrez-Cogco L; Moguel-Pech L; Villanueva-Zamudio A
Rev Latinoam Microbiol; 1994; 36(4):273-6. PubMed ID: 7701137
[TBL] [Abstract][Full Text] [Related]
48. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
Khan MU; Barua DK; Begum T; Shahidullah M
Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
[TBL] [Abstract][Full Text] [Related]
49. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
[TBL] [Abstract][Full Text] [Related]
50. Cholera in the Gilbert Island. I. Epidemiological features.
Kuberski T; Flood T; Tera T
Am J Trop Med Hyg; 1979 Jul; 28(4):677-84. PubMed ID: 464187
[TBL] [Abstract][Full Text] [Related]
51. Protection against cholera in breast-fed children by antibodies in breast milk.
Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Hossain KM; Huq MI; Holmgren J
N Engl J Med; 1983 Jun; 308(23):1389-92. PubMed ID: 6843632
[TBL] [Abstract][Full Text] [Related]
52. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
53. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
54. Cholera antitoxin titrations: a comparative study of fat-cell, ileal-loop, and rabbit-skin assays.
Curlin CT; Mosley WH; Greenough WB
J Infect Dis; 1973 Mar; 127(3):294-8. PubMed ID: 4734668
[No Abstract] [Full Text] [Related]
55. Comparison of paired whole milk and dried filter paper samples for anti-enterotoxin and anti-rotavirus activities.
Brown SE; Sauer KT; Nations-Shields M; Shields DS; Araujo JG; Guerrant RL
J Clin Microbiol; 1982 Jul; 16(1):103-6. PubMed ID: 6286715
[TBL] [Abstract][Full Text] [Related]
56. A polyclonal-monoclonal antibody based sensitive sandwich enzyme linked immunosorbent assay for specific detection of cholera toxin.
Bhadra RK; Biswas T; Pal SC; Takeda T; Nair GB
Zentralbl Bakteriol; 1991 Oct; 275(4):467-73. PubMed ID: 1755920
[TBL] [Abstract][Full Text] [Related]
57. Neutralization of cholera enterotoxin-induced steroidogenesis by specific antibody.
Donta ST
J Infect Dis; 1974 Mar; 129(3):284-8. PubMed ID: 4593242
[No Abstract] [Full Text] [Related]
58. Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.
Holmgren J; Andersson A; Wallerstrom G; Ouchterlony O
Infect Immun; 1972 May; 5(5):662-7. PubMed ID: 4637602
[TBL] [Abstract][Full Text] [Related]
59. [The development of biochip to detect anti-cholera antibodies in human blood serum].
Utkin DV; Osina NA; Spitsin AN; Kireev MN; Gromova OV; Zakharova TL; Naidenova EV; Kuklev VE
Klin Lab Diagn; 2015 Feb; 60(2):50-3. PubMed ID: 26027261
[TBL] [Abstract][Full Text] [Related]
60. Antigenic specificity of neutralizing antibody to cholera toxin.
Peterson JW; Hejtmancik KE; Markel DE; Craig JP; Kurosky A
Infect Immun; 1979 Jun; 24(3):774-9. PubMed ID: 89089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
